What are the monounsaturated fatty acid (MUFA) and polyunsaturated fatty acid (PUFA) contents of coconut oil, and how do they impact cardiovascular risk?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Coconut Oil: MUFA and PUFA Content and Cardiovascular Impact

Coconut oil contains minimal amounts of monounsaturated fatty acids (MUFAs) and polyunsaturated fatty acids (PUFAs)—approximately 6% MUFAs and 2% PUFAs—with the remaining 92% being saturated fats, predominantly medium-chain fatty acids like lauric acid. This composition makes coconut oil fundamentally different from other vegetable oils in its cardiovascular effects.

Fatty Acid Composition

Coconut oil's fatty acid profile is dominated by saturated fats, particularly medium-chain saturated fatty acids (C4-C12), with lauric acid being the most abundant 1. Unlike palm oil, which contains roughly equal amounts of saturated and monounsaturated fats, coconut oil has negligible MUFA and PUFA content 1.

Cardiovascular Risk Profile

Lipid Effects

Coconut oil increases both LDL-cholesterol and HDL-cholesterol compared to unsaturated vegetable oils. The most recent meta-analysis demonstrates that coconut oil consumption increases LDL-cholesterol by 10.47 mg/dL and HDL-cholesterol by 4.00 mg/dL compared to non-tropical vegetable oils 2. This effect persists even when compared specifically to polyunsaturated-rich oils 3.

The saturated fats in coconut oil increase HDL-cholesterol more than LDL-cholesterol relative to dietary carbohydrates, creating what some describe as a "more favorable lipid profile" 1. However, this interpretation is misleading when the comparison is made against unsaturated vegetable oils rather than carbohydrates.

Clinical Evidence Gap

A critical limitation exists: no randomized controlled trials or prospective cohort studies have directly investigated coconut oil consumption and cardiovascular disease outcomes 4. The 2016 Circulation guidelines explicitly state that "sufficient evidence to support strong promotion or avoidance of tropical oils is lacking" and call for "urgent" long-term investigations 5.

Practical Recommendations

Replace Coconut Oil With:

  • Extra-virgin olive oil (high in MUFAs with beneficial polyphenols)
  • Canola oil (contains 10% omega-3 PUFAs)
  • Soybean oil (contains 7% omega-3 PUFAs)
  • Safflower or sunflower oil (high in omega-6 PUFAs)

These oils are supported by stronger evidence for cardiovascular benefit 5, 6.

When Coconut Oil Is Used:

If coconut oil is consumed, it should be:

  • Limited in quantity (not a primary cooking oil)
  • Replaced preferentially with oils rich in PUFAs and MUFAs rather than with refined carbohydrates or animal fats
  • Considered neutral at best compared to butter or lard, but inferior to unsaturated vegetable oils 7, 4

Key Caveats

The medium-chain fatty acids in coconut oil may have metabolic advantages over long-chain saturated fats from animal sources, including faster metabolism and potential antimicrobial properties 1, 8. However, these theoretical benefits do not override the established LDL-cholesterol raising effects when compared to unsaturated oils.

Countries with high tropical oil intake have low heart disease rates 1, but this ecological observation is confounded by overall dietary patterns, physical activity, and other lifestyle factors—not evidence that coconut oil itself is protective.

The 2022 guidelines emphasize that olive oil, soybean, sunflower, safflower, and corn oil are healthier choices than tropical oils rich in saturated fat 7. The evidence consistently supports replacing saturated fats (including those from coconut oil) with unsaturated fats to reduce cardiovascular risk 7, 9.

References

Research

Coconut Oil and Cardiovascular Disease Risk.

Current atherosclerosis reports, 2023

Related Questions

What is the ideal percentage of total daily calories from monounsaturated fatty acids (MUFA) and polyunsaturated fatty acids (PUFA) for a generally healthy adult?
Is coconut oil contraindicated for patients with aortic valve stenosis?
Is refined coconut oil harmful to one's health?
Is vegetable oil a healthier choice than seed oil for cooking, particularly regarding monounsaturated fat content and suitability for high‑heat frying?
What are the health benefits, recommended dosage, and cardiovascular risks of using virgin coconut oil?
What is the appropriate clindamycin dosing regimen for cellulitis in adults and children, including dose adjustments for renal or hepatic impairment?
What is the recommended pediatric dose of oral prednisolone for infantile epileptic spasms syndrome?
What were the long‑term outcomes of the LIRIC (LIR!C) trial comparing laparoscopic ileocaecal resection versus infliximab therapy in adult patients with non‑stricturing, immunomodulator‑refractory ileocaecal Crohn’s disease?
What is the relationship between apolipoprotein E epsilon 4 (APOE4) genotype and lipoprotein(a) (Lp(a)) levels?
Why do constipation and urinary retention in an older adult cause serum lactate to rise?
What is the differential diagnosis for a patient with unexplained weight loss and laboratory findings of low white blood cell count (WBC), low hemoglobin (HGB), high platelet count (PLT), and a peripheral smear showing polychromasia, anisocytosis, macrocytosis, poikilocytosis, basophilic stippling, and burr cells?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.